– Enrolls first clinical trial patients in Sydney, Australia SYDNEY – (ACN Newswire) – Cadrock Pty Ltd, which owns an investigational prevention and treatment therapy for coronary artery disease (CAD),…
HONG KONG – (ACN Newswire) – Everbright Haiyin Fund (“The Fund”), a fund co-initiated and managed by China Everbright Limited (“Everbright”, stock code: 165.HK) and Haiyin Capital, has completed its…
HONG KONG – (ACN Newswire) – According to South China Morning Post’s report, the interim results posted by Legend Holdings Corporation for the six months to the end of June…
